SPL
NKTR icon

Superior Planning, LLC’s Nektar Therapeutics NKTR Stock Holding History

Superior Planning, LLC’s Portfolio NKTR Stock Details NKTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$8.96K Buy
+148
New +$10.4K ﹤0.01% 969

Other funds holding NKTR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Two Seas Capital
Two Seas Capital Rye, New York $8.68B AUM 78.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Emerald Advisers
Emerald Advisers Leola, Pennsylvania $3.64B AUM 71.19% 1-Year Est. Return
Creek Drive Management Group
Creek Drive Management Group San Francisco, California $368M AUM 23.05% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $161B AUM 86.05% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

Superior Planning, LLC's NKTR Position: Q3 2026 in Review

Superior Planning, LLC opened a new position in Nektar Therapeutics (NKTR) in Q3 2026: 148 shares worth $8.96K. The stake represents ﹤0.01% of the portfolio and ranks #969 among its holdings.

125 funds tracked by Wall St. Rank hold NKTR as of Q3 2026.

  • Superior Planning, LLC held 148 shares of Nektar Therapeutics worth $8.96K as of Q3 2026.
  • Nektar Therapeutics was a new Superior Planning, LLC position in Q3 2026.
  • Nektar Therapeutics made up ﹤0.01% of Superior Planning, LLC's portfolio in Q3 2026, its #969 holding.
  • 125 funds tracked by Wall St. Rank held Nektar Therapeutics as of Q3 2026.

Based on Superior Planning, LLC's 13F filing for Q3 2026, filed 12 Nov 2026.